Molecular characterization of immune-related severe adverse events (irSAE)
Balko J., et al. Molecular characterization of immune-related severe adverse events (irSAE). Poster session presented at: The American Society of Clinical Oncology (ASCO), 2017 Jun; Chicago, IL